Reconsider the care assumption
It is a broad word, not a care plan.
A peptide joins protein building blocks into a short chain. Insulin is an example.
The name describes the substance; it does not settle its safety or legal status.
Federal medicine status as of September 26, 2026.
Same word, different products
An approved product
Some peptide drugs have approval from the Food and Drug Administration (FDA). Examples include Ozempic and Wegovy (semaglutide), along with Mounjaro and Zepbound (tirzepatide).
A preparation made to order
Other preparations are compounded for a patient by a pharmacist or doctor instead of arriving as a finished drug from a maker.
Compounding can address a need that an approved product leaves unmet. But the resulting preparation is not FDA-approved.
A research label
A product labelled for research is a different matter. FDA warns against research-labelled weight drugs offered to people with directions for use.
Name the goal before the ingredient
Try a plain sentence: I want help with this health problem. Then ask how the proposed medicine relates to it.
Ask why it was chosen, what else might help, and what would count as a reason to stop or change the plan.
Keep the exact product name in your notes. A broad phrase such as peptide programme leaves too much unanswered.
Take this with you
Words to start the conversation
- What is the exact medicine? Is it a pill, injection or something else?
- Is it an approved product or made to order?
- Why is this option being considered for my goal?
Chapter notes
Evidence for this chapter
- AFDA: understanding approval claims
For what approval does and does not mean.
- BFDA: medicines made to order
For the role and limits of compounding.
- CFDA: research-labelled weight medicines
For the distinction between care and research products.